Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Chinese Patent Office
Baxter
Deloitte
AstraZeneca
Colorcon
Harvard Business School
Julphar

Generated: December 16, 2018

DrugPatentWatch Database Preview

NEUPOGEN Drug Profile

« Back to Dashboard

US Patents for NEUPOGEN

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up Bayer Intellectual Property GMBH (Monheim, DE) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up EnBio Limited (Dublin, IE) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up CARDIONOVUM Sp.z.o.o. (Warsaw, PL) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up Genentech, Inc. (South San Francisco, CA) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up GENMAB A/S (Copenhagen V, DK) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for NEUPOGEN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2010007,C1534390 Lithuania ➤ Sign Up PRODUCT NAME: ELTROMBOPAGUM OLAMINUM; REGISTRATION NO/DATE: EU/1/10/612/001, 2010-03-11 EU/1/10/612/002, 2010-03-11 EU/1/10/612/003, 2010-03-11 EU/1/10/612/004, 2010-03-11 EU/1/10/612/005, 2010-03-11 EU/1/10/612/006 20100311
3-2010 Slovakia ➤ Sign Up PRODUCT NAME: ELTROMBOPAG; FIRST REGISTRATION NO/DATE: EU/1/10/612/001, EU/1/10/612/002, EU/1/10/612/003, EU/1/10/612/004, EU/1/10/612/005, EU/1/10/612/006; 20100311
0100006 00032 Estonia ➤ Sign Up PRODUCT NAME: REVOLADE-ELTROMBOPAG; REG NO/DATE: C(2010)1662 11.03.2010
2010007 Lithuania ➤ Sign Up PRODUCT NAME: ELTROMBOPAGUM OLAMINUM; REGISTRATION NO/DATE: EU/1/10/612/001, 2010 03 11 EU/1/10/612/002, 2010 03 11 EU/1/10/612/003, 2010 03 11 EU/1/10/612/004, 2010 03 11 EU/1/10/612/005, 2010 03 11 EU/1/10/612/006 20100311
2014 00047 Denmark ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140527
90052-6 Sweden ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928 20140522
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Fuji
McKesson
Teva
Boehringer Ingelheim
Medtronic
Mallinckrodt
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.